TGen Clinical Research Services at Scottsdale Healthcare today announced the start of a clinical trial for a drug designed to combat adrenocortical carcinoma (ACC), a rare but deadly cancer that attacks the adrenal glands.
Full article >>
Tuesday, September 22, 2009
Revolutionary drug could be new hope for adrenal cancer patients
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment